Dictionary entry · Health

Bonglai

Zingiber purpureum Roscoe

ENCassumunar ginger, Plai

  • MSBonglai
  • MSMengkulai
  • JVBangle
  • IDBangle
  • ENCassumunar ginger

Synonym: Zingiber cassumunar Roxb.

Family: Zingiberaceae

Zingiber purpureum, historical botanical plate
Zingiber purpureum. William Roscoe, Monandrian Plants of the Order Scitamineae (1828), 'Zingiber cassumunar', via Wikimedia Commons. Public domain. Source.
At a glance

Topical preparations of bonglai rhizome carry limited clinical evidence for minor muscle and joint complaints: one double-blind trial of a plai-and-ginger combination gel in knee osteoarthritis and one randomised trial of a plai cream after eccentric exercise, both small, both Thai, and neither independently replicated.

Parts used
Rhizome
Native range
Introduced or naturalised. Arunachal Pradesh to China (Yunnan) and Myanmar (POWO/WCVP).
Habitat
Garden
Evidence grade
B: Limited clinical evidence

Traditional and heritage uses

Bonglai (bangle in Javanese and Indonesian usage, plai in Thailand) is a
rhizome of the massage and confinement tradition rather than the kitchen.
In the Malay record it belongs above all to postpartum practice: heated
rubs and pastes worked into tired muscle during confinement, with bonglai
recorded among the frequently used species in surveys of Malay traditional
practitioners [1].

A Sarawak ethnography puts it at the centre rather than the margin. Working
with a traditional Malay midwife in Kuching, the study documents irup, the
postpartum decoction of the bidan's practice, and names bangley,
Zingiber cassumunar, as its first ingredient, recorded in tradition for
fever, aching muscle, appetite and wounds [2]. The confinement complex it
sits inside (bengkung binding, postnatal massage, the bertungku hot
compress, herbal baths and jamu) has been reviewed as an integrated
system [3].

The rhizome travels well across the archipelago's households: an
ethnobotanical survey in Sintang, West Kalimantan records it among the
most-used Zingiberaceae across Dayak Linoh, Malay and Javanese
communities, noting how each prepares it [4]. Parallel Thai and Indonesian
records keep the same rhizome in warmed preparations for the body after
labour and exertion [5].

The name-set is part of the record: bonglai and mengkulai are both current
in Malay, bangle across the Strait, and botanists now file the plant under Zingiber purpureum Roscoe. Zingiber cassumunar Roxb., the name most of the older literature uses, is its synonym, while Zingiber montanum is a separate mainland species [6].

Documented in6
  1. Jamal JA, Abd. Ghafar Z, Husain K (2011). Medicinal plants used for postnatal care in Malay traditional medicine in the Peninsular Malaysia. Pharmacognosy Journal 3(24): 15–24. Source
  2. Bolhassan R, Bolhassan R, Rozaimie A (2025). Ethnography of irup (jamu): medicinal disclosure of the traditional Malay's midwifery practices in Sarawak. Journal of Borneo-Kalimantan 11(2): 64–77. Source
  3. Fadzil F, Shamsuddin K, Wan Puteh SE (2016). Traditional postpartum practices among Malaysian mothers: a review. Journal of Alternative and Complementary Medicine 22(7): 503–508. Source
  4. Julung H, Supiandi MI, Ege B, Zubaidah S, Mahanal S (2024). Zingiberaceae rhizome as traditional medicine based on Dayak Linoh, Malay, and Javanese local wisdom. Tropical Journal of Natural Product Research 8(5): 7232–7243. Source
  5. Han A-R, Kim H, Piao D, Jung C-H, Seo EK (2021). Phytochemicals and bioactivities of Zingiber cassumunar Roxb. Molecules 26(8): 2377. Source
  6. POWO (2026). Zingiber purpureum Roscoe. Plants of the World Online, Royal Botanic Gardens, Kew. Accessed 18 October 2026. Source

What the evidence says

B
Evidence grade Limited clinical evidence

Human trials exist but are few, small, or not yet replicated.

What the grades mean
  1. VIISystematic reviewGrade A
  2. VIClinical studiesGrade A–B
  3. VHuman observationalGrade B–C
  4. IVPreclinicalGrade C
  5. IIILaboratoryGrade C
  6. IIPhytochemicalGrade C
  7. ITraditional useGrade C
Human studiesYes: a 2017 systematic review of six studies (355 patients) supports 14% plai cream for muscle pain and ankle sprain but not other indications [8]; later randomised trials cover diabetic neuropathy and knee osteoarthritis [9, 10].

The ladder explains the grade; it never replaces it. Evidence for this plant reaches systematic review, which is why the entry is graded B.

Traditional use

Bonglai (bangle in Javanese and Indonesian usage, plai in Thailand) is a
rhizome of the massage tradition rather than the kitchen. Jamal and
colleagues' 2011 survey of Malay traditional practitioners records
Zingiber cassumunar among the frequently used species in postnatal care,
a practice built around heated rubs and pastes applied to strained muscle
[1]. The Han 2021 review documents parallel Thai and Indonesian traditional
use of the rhizome for muscle and joint complaints, sprains and swelling
[2]. The regional name-set is worth recording precisely: bonglai and
mengkulai are both current in Malay, and the accepted botanical synonym is
Zingiber montanum.

Phytochemistry

Two chemistries coexist in the rhizome. The essential oil is dominated by
monoterpenes: sabinene and terpinen-4-ol chief among them, characterised
in Indonesian material by Taroeno and colleagues in 1991 [3]. The
non-volatile fraction carries the phenylbutenoids, including compound D
((E)-4-(3,4-dimethoxyphenyl)but-3-en-1-ol) and DMPBD, inventoried in the
Han 2021 review [2]. DMPBD is the best-studied constituent in the
laboratory: Jeenapongsa and colleagues (2003) showed it dose-dependently
reduced experimentally induced ear oedema in rats, outperforming the
standard comparator compounds in that model [4]. DMPBD is also chemically
unstable, which raises real standardisation questions for any commercial
balm.

Evidence review

Two randomised trials anchor the grade. Niempoog and colleagues (2012) ran
a double-blind trial of Plygersic gel (a combination of plai and ginger
(Zingiber officinale) extracts) against 1% diclofenac gel in 100
patients with knee osteoarthritis over six weeks, and reported improved
KOOS scores with no significant difference between the gels [5]. Because
the gel combined two species, the trial cannot isolate bonglai's
contribution. Manimmanakorn and colleagues (2016) randomised 75 volunteers
to 14% or 7% plai cream or placebo, rubbed in after eccentric quadriceps
exercise, measuring soreness, strength, jump height and creatine kinase
over seven days [6]: a single-plant trial, in healthy volunteers rather
than patients.

Both trials are small, short, and from a single country, and no systematic
review meeting our inclusion criteria exists. Evidence for bonglai reaches
early clinical study; the grade remains B until independent replication
with a standardised, single-species preparation is published.

A systematic review published in 2017 gathered six studies covering 355
patients and concluded that a 14% plai cream is supported for muscle pain
and ankle sprain, while other proposed indications are not [8]. Later
randomised work has extended the range without settling it: a
placebo-controlled trial of a 15% balm in painful diabetic neuropathy
reported reduced pain at two and four weeks [9], and a trial in knee
osteoarthritis delivered the extract by phonophoresis [10]. Mechanistic
work continues on the phenylbutenoids that carry the activity [11], and
formulation studies address the skin permeation and stability of compound
D: a practical problem, given the instability noted above [12].

The systematic-review rung is therefore reached. What it found, however,
is limited and indication-specific evidence, which is why the grade sits
at B rather than higher.

Open questions4
  • The strongest joint-pain trial tested a plai-and-ginger combination gel; no randomised trial isolates Zingiber cassumunar alone in patients.
  • Both existing trials are small, short and from Thailand; independent replication elsewhere is the open question the grade waits on.
  • Dermal sensitisation and irritation data at balm concentrations are thin, and DMPBD instability raises shelf-life and standardisation questions for commercial products.
  • The 2017 systematic review supports a 14% plai cream for muscle pain and ankle sprain specifically [8]; whether a differently formulated balm inherits that support is untested.

Cautions and safety

Oral toxicity studies are reassuring: Koontongkaew and colleagues (2014)
found no treatment-related toxicity at a single 5,000 mg/kg dose in rats
and set a 270-day no-observed-adverse-effect level at 1,125 mg/kg/day [7].
Dermal safety data are thinner than the oral data. Patch-test before use;
do not apply to broken skin; the undiluted essential oil can irritate.
Data in pregnancy are limited: traditional postpartum use notwithstanding,
concentrated extracts deserve professional advice first.

This entry records documented traditional use. This is not medical advice; speak to a qualified practitioner.

Sources (15)

  1. Jamal JA, Abd. Ghafar Z, Husain K (2011). Medicinal plants used for postnatal care in Malay traditional medicine in the Peninsular Malaysia. Pharmacognosy Journal 3(24): 15–24. Source
  2. Han A-R, Kim H, Piao D, Jung C-H, Seo EK (2021). Phytochemicals and bioactivities of Zingiber cassumunar Roxb. Molecules 26(8): 2377. Source
  3. Taroeno, Brophy JJ, Zwaving JH (1991). Analysis of the essential oil of Zingiber cassumunar Roxb. from Indonesia. Flavour and Fragrance Journal 6(2): 161–163. Source
  4. Jeenapongsa R, Yoovathaworn K, Sriwatanakul KM, et al. (2003). Anti-inflammatory activity of (E)-1-(3,4-dimethoxyphenyl)butadiene from Zingiber cassumunar Roxb. Journal of Ethnopharmacology 87(2–3): 143–148. Source
  5. Niempoog S, Siriarchavatana P, Kajsongkram T (2012). The efficacy of Plygersic gel for use in the treatment of osteoarthritis of the knee. Journal of the Medical Association of Thailand 95(Suppl 10): S113–S119. Source
  6. Manimmanakorn N, Manimmanakorn A, Boobphachart D, Thuwakum W, Laupattarakasem W, Hamlin MJ (2016). Effects of Zingiber cassumunar (Plai cream) in the treatment of delayed onset muscle soreness. Journal of Integrative Medicine 14(2): 114–120. Source
  7. Koontongkaew S, et al. (2014). Safety evaluation of Zingiber cassumunar Roxb. rhizome extract: acute and chronic toxicity studies in rats. International Scholarly Research Notices 2014: 632608. Source
  8. Bolhassan R, Bolhassan R, Rozaimie A (2025). Ethnography of irup (jamu): medicinal disclosure of the traditional Malay's midwifery practices in Sarawak. Journal of Borneo-Kalimantan 11(2): 64–77. Source
  9. Julung H, Supiandi MI, Ege B, Zubaidah S, Mahanal S (2024). Zingiberaceae rhizome as traditional medicine based on Dayak Linoh, Malay, and Javanese local wisdom. Tropical Journal of Natural Product Research 8(5): 7232–7243. Source
  10. Chongmelaxme B, Sruamsiri R, Dilokthornsakul P, et al. (2017). Clinical effects of Zingiber cassumunar (Plai): a systematic review. Complementary Therapies in Medicine 35: 70–77. Source
  11. Jatuten N, Piyakunmala P, Budkaew J, Chumworathayi B (2023). Effect of topical Zingiber cassumunar on painful diabetic neuropathy: a double-blind randomized-controlled trial. F1000Research 12: 334. Source
  12. Joshi MV, Phansopkar P (2022). Effect of Zingiber cassumunar Roxb. phonophoresis versus aqua sonic gel on pain, range of motion, and functional disability in patients with osteoarthritis of knee: a randomized controlled trial. Cureus 14(12): e32760. Source
  13. Gundom T, Sukketsiri W, Panichayupakaranant P (2025). Phytochemical analysis and biological effects of Zingiber cassumunar extract and three phenylbutenoids: targeting NF-κB, Akt/MAPK, and caspase-3 pathways. BMC Complementary Medicine and Therapies 25(1): 180. Source
  14. Priprem A, Janpim K, Nualkaew S, Mahakunakorn P (2016). Topical niosome gel of Zingiber cassumunar Roxb. extract for anti-inflammatory activity, enhanced skin permeation and stability of compound D. AAPS PharmSciTech 17(3): 631–639. Source
  15. Kamazeri TS, Samah OA, Taher M, Susanti D, Qaralleh H (2012). Antimicrobial activity and essential oils of Curcuma aeruginosa, Curcuma mangga, and Zingiber cassumunar from Malaysia. Asian Pacific Journal of Tropical Medicine 5(3): 202–209. Source